http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019048666-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc0066975a4178b91e12873a8539f4f1
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6812
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
filingDate 2018-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd8ea13d9add6bba56aecb939ef7ea9f
publicationDate 2019-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2019048666-A1
titleOfInvention POLYPEPTIDES FOR THE TREATMENT OF DISEASES
abstract The present invention relates to a polypeptide having the general amino acid sequence written as a single letter code Z 1 IX 2 RWX 5 X 6 KX 8 PX 10 X 11 SZ 3, X 2 = V, M or L, particularly L , X 5 = S or T, X 6 = K or R, in particular R, X 8 = V, M, L or F, in particular M, X 10 = Q or C, in particular C, X 11 = V, M or F, especially V; Z 1 = 0, Z 2 , or pyro glutamate, Z 2 = being a modification of the N-terminal nitrogen atom of the peptide chain, which modification forms together with the amino group of the N-terminal amino acid of peptide a moiety having the structure -NR 2 R 3 , R 2 and / or R 3 being independently of each other H or a substituted or unsubstituted acyl, alkyl, aryl, aralkyl, cycloalkyl and heterocycloalkyl group; Z 3 = 0, or Z 4 , Z 4 = being a modification of the C-terminal carboxyl group of the peptide chain, which modification together with the carboxyl group of the C-terminal amino acid of the peptide forms a fraction having the structure C (O) -OR 1 or -C (O) -NR 2 R 3 , R 1 being a substituted or unsubstituted alkyl, aryl, aralkyl, cycloalkyl and heterocycloalkyl group; and R 2 and R 3 are as defined above.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020094843-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11377651-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11708572-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10785574-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10704021-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021170782-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10975368-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3872084-A1
priorityDate 2017-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009004054-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014198834-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399600
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395968
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226606545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9475
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17802677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID773

Total number of triples: 43.